Loading...

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

2315.HK•HKSE
Healthcare
Biotechnology
HK$26.34
HK$0.69(2.69%)

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) Stock Chart & Performance Analysis

Explore Biocytogen Pharmaceuticals (Beijing) Co., Ltd.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-0.96%
5-Day Change
-3.88%
1-Month Change
12.55%
3-Month Change
60.78%
6-Month Change
65.95%
Year-to-Date (YTD) Change
49.16%
1-Year Change
102.62%
3-Year Change
-52.38%
5-Year Change
-52.38%
All-Time (Max) Change
-52.38%

Analyzing Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) Trends Across Multiple Time Frames

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. stock shows -0.96% 1-day change, indicating low volatility, while its 5-day change of -3.88% suggests a broader trend. Over a 1-month period, a 12.55% rise could signal a pushback, whereas a 3-month rise of 60.78% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 65.95% and a YTD rise of 49.16% might concern investors, but a 1-year gain of 102.62% and a 3-year drop of -52.38% could indicate resilience. The 5-year surge of -52.38% highlights weak historical growth, while the all-time return of -52.38% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;